Related Experiment Videos
Nontransformed colony-derived stromal cell lines from normal human marrows. II. Phenotypic characterization and
Experimental Hematology
|February 1, 1995
Summary
This study characterizes colony-derived cell lines (CDCL) from human bone marrow cultures, revealing they are non-hematopoietic stromal cells. These CDCL exhibit diverse proliferation rates and differentiate into vascular smooth muscle-like cells, suggesting genetic and cytokine regulation.
Area of Science:
- Cell Biology
- Stem Cell Research
- Tissue Engineering
Background:
- Stromal cells play crucial roles in tissue maintenance and regeneration.
- Previous methods established a way to generate colony-derived cell lines (CDCL).
- Understanding the phenotype and behavior of CDCL is essential for their potential applications.
Purpose of the Study:
- To comprehensively describe the phenotype of over 100 CDCL.
- To investigate the proliferative capacity and differentiation patterns of CDCL.
- To explore the regulatory mechanisms controlling CDCL development.
Main Methods:
- Human long-term bone marrow cultures (LTBMC) were used to generate stromal colonies.
- Colonies were cultured in liquid medium with basic fibroblast growth factor (bFGF) to establish CDCL.
- Phenotypic characterization included analysis of membrane antigens, extracellular matrix synthesis, and protein expression over time.
Main Results:
- CDCL were confirmed to be non-hematopoietic and non-endothelial stromal cells, expressing markers like 6-19, Stro-1, and 1B10.
- Cells synthesized interstitial collagens, fibronectin, tenascin, and chondroitin-sulfate.
- CDCL displayed varied proliferative capacities (32% fast, 36% slow, 32% intermediate).
- CDCL with high proliferation potential differentiated into cells resembling immature vascular smooth muscle cells, expressing specific cytoskeletal and ECM proteins (e.g., alpha-SM-actin, SMMHC, collagen IV, elastin).
Conclusions:
- CDCL represent a valuable model for studying stromal cell biology and differentiation.
- The differentiation of CDCL into vascular smooth muscle-like cells suggests potential in regenerative medicine.
- Both genetic factors and cytokines likely regulate the proliferation and differentiation of CDCL.